Morphologic and biologic studies on ten cases of verrucous carcinoma of the vulva supporting the theory of a discrete clinico-pathologic entity

International Journal of Gynecological Cancer

Volumn 13, Issue 3, 2003, Pages 317-324

  Gualco, M ^a   Bonin, S ^b   Foglia, G ^a   Fulcheri, Ezio ^a   Odicino, F ^a   Prefumo, F ^a   Stanta, G ^b,c   Ragni, N ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

Human papillomavirus (HPV); Keratins; MIB 1; p53; Verrucous carcinoma; Vulva

Indexed keywords

CYTOKERATIN; CYTOKERATIN AE1; CYTOKERATIN AE3; KERATIN; KI 67 ANTIGEN; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; CELL PROLIFERATION; CELL STRUCTURE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA PROBE; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MUTANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE FIXATION; TUMOR SUPPRESSOR GENE; VERRUCOUS CARCINOMA; VIRUS STRAIN; VULVA CARCINOMA; VULVECTOMY; WART VIRUS; WILD TYPE; GENETICS; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; VIROLOGY; VULVA TUMOR;

AGED; AGED, 80 AND OVER; CARCINOMA, VERRUCOUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MIDDLE AGED; POLYMERASE CHAIN REACTION; VULVAR NEOPLASMS;

EID: 0642284872     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2003.13200.x     Document Type: Article

References (33)

1. Ackerman LV. Verrucous carcinoma of the oral cavity. Surgery 1948;23:670-8.
2. Kraus FT, Pérez-Mesa C. Verrucous carcinoma, clinical and pathologic study of 105 cases involving oral cavity, larynx and genitalia. Cancer 1966;19:26-38.
3. Crowther ME, Lowe DG, Shepherd JH. Verrucous carcinoma of the female genital tract: a review. Obstet Gynecol Surv 1988;43:263-80.
4. Brisigotti M, Moreno A, Murcia C, Matias Guiu X, Prat J. Verrucous carcinoma of the vulva. A clinicopathologic and immunohistochemical study of five cases. Int J Gynecol Pathol 1989;8:1-7.
5. Japaze H, Dinh TV, Woodruff JD. Verrucous carcinoma of the vulva: study of 24 cases. Obstet Gynecol 1982;60:462-6.
6. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase (ABC) in immunoperoxidase technique. A comparison between ABC and unlabeledantibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
7. Cooper D, Schermer A, Tung Tien S. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratin: strategies, applications and limitations. Lab Invest 1985;52:243-56.
8. Dvoretsky PM, Bonfiglio TA. The pathology of vulvar squamous cell carcinoma and verrucous carcinoma. Pathol Annu 1986;21:23-45.
9. Dinh TV, Powell LC, Hannigan EV, Yang HL, Wirt DP, Yandell RB. Simultaneously occurring condylomata acuminata, carcinoma in situ and verrucous carcinoma of the vulva and carcinoma in situ of the cervix in a young woman. A case report. J Reprod Med 1988;33:510-3.
10. Gupta J, Pilotti S, Shah KV, De Palo G, Rilke F. Human papillomavirus associated early vulvar neoplasia investigated by in situ hybridization. Am J Surg Pathol 1987;11:430-4.
11. Monk BJ, Burger RA, Lin F, Parham G, Vasilev SA, Wilczynski SP. Prognostic significance of human papillomavirus DNA in vulvar carcinoma. Obstet Gynecol 1995;85:709-15.
12. Gissmann L, de Villiers EM, zur Hausen H. Analysis of human genital warts (condylomata acuminatum) and other genital tumours for HPV type 6 DNA. Int J Cancer 1982;29:143-6.
13. Rando RF, Sedlacek TV, Hunt J, Jenson AB, Kurman RJ, Lancaster WP. Verrucous carcinoma of the vulva associated with an unusual type 6 Human Papilloma Virus. Obstet Gynecol 1986;67:70-5.
14. Okagaki T. Female genital tumours associated with human papillomavirus infection, and the concept of genital neoplasm papilloma syndrome (GENPS). Pathol Annu 1984;19:31-62.
15. Kondi-Paphitis A, Deligeorgi-Politi H, Liapis A, Plemenou-Frangou M. Human papilloma virus in verrucus carcinoma of the vulva: an immunopathological study of three cases. Eur J Gynaecol Oncol 1998;19:319-20.
16. Van Sickle M, Kaufman RH, Adam E, Adler Storthz K. Detection of human papillomavirus DNA before and after development of invasive vulvar cancer. Obstet Gynecol 1990;76:540-2.
17. Crowther ME, Shepherd JH, Fisher C. Verrucous carcinoma of the vulva containing human papillomavirus 11. Case report. Br J Obstet Gynaecol 1988;95:414-8.
18. Della Torre G, Donghi R, Longoni A et al. HPV DNA in intraepithelial neoplasia and carcinoma of the vulva and penis. Diagn Mol Pathol 1992;1:25-30.
19. Milde-Langosch K, Becker G, Loning T. Human papillomavirus and c-myc/c-erbB2 in uterine and vulvar lesions. Virchows Arch a Pathol Anat Histopatol 1991;419:479-85.
20. Djurdjevic S, Devaja O, Hadzic B. Malignant potential of gigantic condylomatous lesions of the vulva. Eur J Gyanecol Oncol 1999;20:63-6.
21. Sagerman PM, Choi YJ, Hu Y, Niedt GW. Human papilloma virus, vulvar dystrophy, and vulvar carcinoma: differential expression of human papillomavirus and vulvar dystrophy in the presence and absence of squamous cell carcinoma of the vulva. Gynecol Oncol 1996;61:328-32.
22. Toki T, Kurman RJ, Park JS, Kessis T, Daniel RW, Shah KV. Probable nonpapillomavirus etiology of squamous cell carcinoma of the vulva in older women: a clinicopathologic study using in situ hybridization and polymerase chain reaction. Int J Gynecol Pathol 1991;10:107-25.
23. Hording U, Junge J, Daugaard S, Lundvall F, Poulsen H, Bock JE. Vulvar squamous cell carcinoma and papillomavirus: indications for two different etiologies. Gynecol Oncol 1994;52:241-6.
24. Trimble CL, Hildesheim A, Brinton LA, Shah KV, Kurman RJ. Heterogeneous etiology of squamous carcinoma of the vulva. Obstet Gynecol 1996;87:59-64.
25. Lerma E, Matias-Guiu X, Lee SJ, Prat J. Squamous cell carcinoma of the vulva: study of ploidy, HPV, p53, and pRb. Int J Gynecol Pathol 1999;18:191-7.
26. Al-Ghamdi A, Freedman D, Miller D et al. Vulvar squamous cell carcinoma in young women, a clinicopathologic study of 21 cases. Gynecol Oncol 2002;84:94-101.
27. Pilotti SD, Amato L, Della Torre G et al. Papillomavirus, p53 alteration, and primary carcinoma of the vulva. Diagn Mol Pathol 1995;4:239-48.
28. Milde-Langosch K, Albrecht K, Joram S, Schlechte H, Giessing M, Loning T. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva. Int J Cancer 1995;63:639-45.
29. Kim YT, Thomas NF, Kessis TD, Wilkinson EJ, Hedrick L, Cho KR. p53 mutations and clonality in vulvar carcinomas and squamous hyperplasias: evidence suggesting that squamous hyperplasias do not serve as direct precursors of human papilomavirus-negative vulvar carcinomas. Hum Pathol 1996;27:389-95.
30. Lee YY, Wilczynski SP, Chumakov A, Chih D, Koeffler HP. Carcinoma of the vulva: HPV and p53 mutations. Oncogene 1994;9:1655-9.
31. Esquius J, Brisigotti M, Matias-Guiu X, Prat J. Keratin expression in normal vulva, non neoplastic epithelial disorders, vulvar intraepithelial neoplasia, and invasive squamous cell carcinoma. Int J Gynecol Pathol 1991;10:341-55.
32. Dische S, Saunders MI, Bennett MH, Wilson GD, McNally NJ. Cell proliferation and differentiation in squamous cancer. Radiother Oncol 1989;15:19-23.
33. Hendricks JB, Wilkinson EJ, Kubilis P, Drew P, Blaydes SM, Munakata S. Ki-67 expression in vulvar carcinoma. Int J Gynecol Pathol 1994;13:205-10.